Inhibrx Biosciences, Inc. (INBX) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $7.99M | -94.0% |
| 2024 | $133.58M | +207.1% |
| 2023 | $43.50M | -25.1% |
| 2022 | $58.06M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $7.99M | -94.0% |
| 2024 | $133.58M | +207.1% |
| 2023 | $43.50M | -25.1% |
| 2022 | $58.06M | — |